From regulatory strategy to quality systems and product commercialization, our experts share practical guidance to help medical device, pharmaceutical, and biotech companies accelerate compliance and reduce risk.
On September 28–29, 2026, the European Medicines Agency (EMA), together with partners in the European Medicines Regulatory Network, convened a multi-stakeholder workshop dedicated to women’s health. The meeting brought together regulators, patients, healthcare professionals, academia, industry, and global partners to examine existing evidence gaps, identify research priorities, and consider opportunities to strengthen medicines development and clinical research.
